Table 1.
Patient Characteristics (n=111)
| n (%) | |
|---|---|
| Gender (female) | 61 (54%) |
| Age, m (SD) | 57.9 (13.9) |
| Race | |
| White | 94 (85%) |
| Black/African American | 10 (9%) |
| Asian | 3 (3%) |
| Don’t know | 1 (0.9%) |
| Ethnicity | |
| Non-Hispanic/Latino | 101 (91%) |
| Hispanic/Latino | 6 (5%) |
| Highest education level | |
| Some high school | 3 (3%) |
| High school diploma | 22 (20%) |
| Some college | 33 (29%) |
| College degree | 23 (21%) |
| Higher level degree | 30 (27%) |
| Marital Status | |
| Married | 68 (61%) |
| Single | 21 (19%) |
| Divorced | 15 (14%) |
| Widowed | 7 (6%) |
| Average Income per person in household | |
| 0-15K | 35 (31%) |
| 15-25K | 22 (20%) |
| 25-40K | 27 (24%) |
| 40-60K | 5 (5%) |
| 60-75K | 0 (0%) |
| 75-100K | 3 (3%) |
| >100K | 4 (4%) |
| Insurance Type | |
| Private | 55 (49%) |
| Medicare | 37 (31%) |
| Medicaid | 16 (17%) |
| Other | 3 (2%) |
| Cancer type | |
| Colorectal | 23 (21%) |
| Other cancer type | 16 (15%) |
| Ovarian | 15 (13%) |
| Lung | 14 (12%) |
| Pancreatic/ Liver | 11 (10%) |
| Breast | 9 (8%) |
| Prostate | 6 (5%) |
| Uterine/urinary | 4 (4%) |
| Head and Neck | 3 (3%) |
| Leukemia/Leukemia | 7 (6%) |
| Esophageal/gastric | 2 (2%) |
| Cancer stage at diagnosis | |
| I | 13 (12%) |
| II | 3 (3%) |
| III | 14 (12%) |
| IV | 72 (64%) |
| N/A | 11 (10%) |
| Metastatic disease | 89 (80%) |
| Years since diagnosis | |
| ≤1 | 54 (48.6%) |
| 1-3 | 25 (23%) |
| >3 | 29 (27%) |
| Any treatment history | |
| Chemotherapy | 93 (83%) |
| Immunotherapy | 30 (27%) |
| Radiation | 46 (41%) |
| Surgery | 71 (64%) |
| Treatment last 6 weeks | 78 (70%) |
| Surgery last 3 months | 35 (32%) |
| Outpatient pain medication use (self-report) | |
| Opioids | 75 (43%) |
| Short-acting opioids | 41 (36%) |
| Long-acting opioids | 24 (21%) |
| OTC | 45 (26%) |
| Acetaminophen | 35 (20%) |
| Ibuprofen | 19 (11%) |
| Other RX pain meds | 16 (9%) |
| Cannabis | 15 (9%) |
| Prescription(s) given at discharge | |
| Opioids (for those without previous use) | |
| Single opioid on discharge | 19 (17%) |
| Non-opioid pain medication | 41 (36%) |
| Acetaminophen | 31 (28%) |
| Gabapentin | 8 (7%) |
| Ibuprofen | 1 (1%) |
| Pain on admission to ED | |
| Chronic pain prior to cancer diagnosis | 31 (27%) |
| Pain severity | 5.4 ± 1.9 |
| Psychological symptoms on admission to ED | |
| Depression PROMIS (T-score) | 54.1 ± 9.7 |
| Anxiety PROMIS (T-score) | 54.9 ± 10.9 |
| Sleep PROMIS (T-score) | 57.0 ± 8.4 |
| Pain Catastrophizing | 18.7 ± 12.5 |
| Perceived Stress Scale | 6.9 ± 3.2 |